Using murine bifunctional T cells created by retroviral transfer of a chimeric immunoglobulin receptor specific for an ovarian cancer-associated tumor antigen to alloreactive T cells, Kershaw and colleagues were able to demonstrate in vivo expansion in response to alloimmunization and demonstrated anti-tumor activity [20]. Here, MPIG6B is linked to ovarian carcinoma.